Cannabidiol reduces leukemic cell size - But is it important?

Frontiers in Pharmacology

Volumn 8, Issue MAR, 2017, Pages

  Kalenderoglou, Nikoletta ^a   Macpherson, Tara ^a   Wright, Karen L ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Cannabidiol; Cell size; Jurkat; Leukaemia; Physiological normoxia; Protein kinase B; Ribosomal protein S6

Indexed keywords

CANNABIDIOL; DOXORUBICIN; MAMMALIAN TARGET OF RAPAMYCIN; OXYGEN; PROTEIN KINASE B; PROTEIN S6;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL COUNT; CELL DEATH; CELL POPULATION; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; JURKAT CELL LINE; LEUKEMIA CELL;

EID: 85016149112     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00144     Document Type: Article

References (35)

1. Atkuri, K. R., Herzenberg, L. A., Niemi, A. K., Cowan, T., and Herzenberg, L. A. (2007). Importance of culturing primary lymphocytes at physiological oxygen levels. Proc. Natl. Acad. Sci. U.S.A. 104, 4547-4552. doi: 10.1073/pnas.0611732104
2. Börner, C., Höllt, V., Sebald, W., and Kraus, J. (2007). Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J. Leukoc. Biol. 81, 336-343. doi: 10.1189/jlb.0306224
3. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., et al. (1993). Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173-180. doi: 10.1111/j.1432-1033.1993.tb17910.x
4. Daaka, Y., Friedman, H., and Klein, T. W. (1996). Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J. Pharmacol. Exp. Ther. 276, 776-783.
5. Dorff, T. B., Groshen, S., Garcia, A., Shah, M., Tsao-Wei, D., Pham, H., et al. (2016). Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 16:360. doi: 10.1186/s12885-016-2370-6
6. Finlay, G. J., Wilson, W. R., and Baguley, B. C. (1986). Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines. Eur. J. Cancer Clin. Oncol. 22, 655-662. doi: 10.1016/0277-5379(86)90162-8
7. Fowler, C. J. (2015). Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: a critical examination of the preclinical literature. Clin. Pharmacol. Ther. 97, 587-596. doi: 10.1002/cpt.84
8. Freeburn, R. W., Wright, K. L., Burgess, S. J., Astoul, E., Cantrell, D. A., and Ward, S. G. (2002). Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169, 5441-5450. doi: 10.4049/jimmunol.169.10.5441
9. Fumarola, C., La Monica, S., Alfieri, R. R., Borra, E., and Guidotti, G. G. (2005). Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis. Cell Death Discov. 12, 1344-1357. doi: 10.1038/sj.cdd.4401660
10. Guo, C. W., Kawakatsu, M., Idemitsu, M., Urata, Y., Goto, S., Ono, Y., et al. (2013). Culture under low physiological oxygen conditions improves the stemness and quality of induced pluripotent stem cells. J. Cell. Physiol. 228, 2159-2166. doi: 10.1002/jcp.24389
11. Herrera, B., Carracedo, A., Diez-Zaera, M., Gómez del Pulgar, T., Guzmán, M., and Velasco, G. (2006). The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp. Cell Res. 312, 2121-2131. doi: 10.1016/j.yexcr.2006.03.009
12. Herrera, B., Carracedo, A., Diez-Zaera, M., Guzmán, M., and Velasco, G. (2005). p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. FEBS Lett. 579, 5084-5088. doi: 10.1016/j.febslet.2005.08.021
13. Holmfeldt, L., Wei, L., Diaz-Flores, E., Walsh, M., Zhang, J., Ding, L., et al. (2013). The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet. 45, 242-252. doi: 10.1038/ng.2532
14. Jacobsson, S. O., Rongård, E., Stridh, M., Tiger, G., and Fowler, C. J. (2000). Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol. 60, 1807-1813. doi: 10.1016/S0006-2952(00)00492-5
15. Jia, W., Hegde, V. L., Singh, N. P., Sisco, D., Grant, S., Nagarkatti, M., et al. (2006). Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol. Cancer Res. 4, 549-562. doi: 10.1158/1541-7786.MCR-05-0193
16. Lee, C., Raffaghello, L., and Longo, V. D. (2012). Starvation, detoxification, and multidrug resistance in cancer therapy. Drug Resist. Updat. 15, 114-122. doi: 10.1016/j.drup.2012.01.004
17. Lombard, C., Nagarkatti, M., and Nagarkatti, P. S. (2005). Targeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in Delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells. Leuk. Res. 29, 915-922. doi: 10.1016/j.leukres.2005.01.014
18. Macpherson, T., Armstrong, J. A., Criddle, D. N., and Wright, K. L. (2014). Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol. In Vitro Cell Dev. Biol. Anim. 50, 417-426. doi: 10.1007/s11626-013-9719-9
19. Massi, P., Solinas, M., Cinquina, V., and Parolaro, D. (2013). Cannabidiol as potential anticancer drug. Br. J. Clin. Pharmacol. 75, 303-312. doi: 10.1111/j.1365-2125.2012.04298.x
20. McAllister, S. D., Soroceanu, L., and Desprez, P. Y. (2015). The antitumor activity of plant-derived non-psychoactive cannabinoids. J Neuroimmune Pharmacol. 10, 255-267. doi: 10.1007/s11481-015-9608-y
21. McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S., and Nagarkatti, M. (2006). Cannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol. Pharmacol. 70, 897-908. doi: 10.1124/mol.106.023937
22. McKallip, R. J., Lombard, C., Fisher, M., Martin, B. R., Ryu, S., Grant, S., et al. (2002). Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 100, 627-634. doi: 10.1182/blood-2002-01-0098
23. Mendivil-Perez, M., Velez-Pardo, C., and Jimenez-Del-Rio, M. (2015). Doxorubicin induces apoptosis in Jurkat cells by mitochondria-dependent and mitochondria-independent mechanisms under normoxic and hypoxic conditions. Anticancer Drugs 26, 583-598. doi: 10.1097/CAD.0000000000000223
24. Papa, V. M., Shen, M. L., and Ou, D. W. (1990). The effects of pH and temperature on the in vitro bindings of delta-9-tetrahydrocannabinol and other cannabinoids to bovine serum albumin. J. Pharm. Biomed. Anal. 8, 353-356. doi: 10.1016/0731-7085(90)80049-U
25. Rao, G. K., Zhang, W., and Kaminski, N. E. (2004). Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. J. Leukoc. Biol. 75, 884-892. doi: 10.1189/jlb.1203638
26. Rosenbluth, M. J., Lam, W. A., and Fletcher, D. A. (2006). Force microscopy of nonadherent cells: a comparison of leukemia cell deformability. Biophys. J. 90, 2994-3003. doi: 10.1529/biophysj.105.067496
27. Ruvinsky, I., Sharon, N., Lerer, T., Cohen, H., Stolovich-Rain, M., Nir, T., et al. (2005). Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19, 2199-2211. doi: 10.1101/gad.351605
28. Sancho, R., de la Vega, L., Appendino, G., Di Marzo, V., Macho, A., and Munoz, E. (2003). The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway. Br. J. Pharmacol. 140, 1035-1044. doi: 10.1038/sj.bjp.0705532
29. Sarker, K. P., and Maruyama, I. (2003). Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol. Life Sci. 60, 1200-1208. doi: 10.1007/s00018-003-3055-2
30. Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., and Kaminski, N. E. (1997). Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278-287. doi: 10.1006/taap.1996.8034
31. Schneider, U., Schwenk, H. U., and Bornkamm, G. (1977). Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19, 621-626. doi: 10.1002/ijc.2910190505
32. Shan, X., Czar, M. J., Bunnell, S. C., Liu, P., Liu, Y., Schwartzberg, P. L., et al. (2000). Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20, 6945-6957. doi: 10.1128/MCB.20.18.6945-6957.2000
33. Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E., and Prasad, A. (2011). Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy. Mol. Cancer Ther. 10, 1161-1172. doi: 10.1158/1535-7163.MCT-10-1100
34. Singh, Y., and Bali, C. (2013). Cannabis extract treatment for terminal acute lymphoblastic leukemia with a philadelphia chromosome mutation. Case Rep. Oncol. 6, 585-592. doi: 10.1159/000356446
35. Van Klingeren, B., and Ten Ham, M. (1976). Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol. Antonie Van Leeuwenhoek 42, 9-12. doi: 10.1007/BF00399444